P
Proton Rahman
Researcher at Memorial University of Newfoundland
Publications - 203
Citations - 14432
Proton Rahman is an academic researcher from Memorial University of Newfoundland. The author has contributed to research in topics: Psoriatic arthritis & Medicine. The author has an hindex of 50, co-authored 170 publications receiving 12294 citations. Previous affiliations of Proton Rahman include University of Michigan & Leiden University Medical Center.
Papers
More filters
Journal ArticleDOI
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair,Kristina Callis Duffin,Cynthia Helms,Jun Ding,Philip E. Stuart,David E. Goldgar,Johann E. Gudjonsson,Yun Li,Trilokraj Tejasvi,Bing Jian Feng,Andreas Ruether,Stefan Schreiber,Michael Weichenthal,Dafna D. Gladman,Proton Rahman,Steven J. Schrodi,Sampath Prahalad,Sampath Prahalad,Stephen L. Guthery,Stephen L. Guthery,Judith Fischer,Wilson Liao,Pui-Yan Kwok,Alan Menter,G. Mark Lathrop,Carol Wise,Ann B. Begovich,John J. Voorhees,James T. Elder,James T. Elder,Gerald G. Krueger,Anne M. Bowcock,Gonçalo R. Abecasis +32 more
TL;DR: The results provide strong support for the association of at least seven genetic loci and psoriasis (each with combined P < 5 × 10−8) and suggest priority targets for study in other auto-immune disorders.
Journal ArticleDOI
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
David M. Evans,Spencer Cca.,J J Pointon,Zhan Su,D Harvey,Grazyna Kochan,Udo Oppermann,Alexander T. Dilthey,Matti Pirinen,Millicent A. Stone,L H Appleton,Loukas Moutsianas,Stephen Leslie,T. W. H. Wordsworth,Tony J. Kenna,Tugce Karaderi,Gethin P. Thomas,Minghong Ward,Michael H. Weisman,C. Farrar,Linda A. Bradbury,Patrick Danoy,Robert D. Inman,Walter P. Maksymowych,Dafna D. Gladman,Proton Rahman,Ann W. Morgan,Helena Marzo-Ortega,Paul Bowness,Karl Gaffney,Gaston Jsh.,Malcolm D. Smith,Jácome Bruges-Armas,Couto A-R.,Rosa Sorrentino,Fabiana Paladini,Manuel A. R. Ferreira,Huji Xu,Yu Liu,L. Jiang,Carlos López-Larrea,Roberto Díaz-Peña,Antonio López-Vázquez,Tetyana Zayats,Céline Bellenguez,Hannah Blackburn,Jenefer M. Blackwell,Elvira Bramon,Suzannah Bumpstead,Juan P. Casas,Aiden Corvin,N. Craddock,Panagiotis Deloukas,Serge Dronov,Audrey Duncanson,Sarah Edkins,Colin Freeman,Matthew W. Gillman,Emma Gray,R. Gwilliam,Naomi Hammond,Sarah E. Hunt,Janusz Jankowski,Alagurevathi Jayakumar,Cordelia Langford,Jennifer Liddle,Hugh S. Markus,Christopher G. Mathew,O. T. McCann,Mark I. McCarthy,Palmer Cna.,Leena Peltonen,Robert Plomin,Simon C. Potter,Anna Rautanen,Radhi Ravindrarajah,Michelle Ricketts,Nilesh J. Samani,Stephen Sawcer,A. Strange,Richard C. Trembath,Ananth C. Viswanathan,Ananth C. Viswanathan,Matthew Waller,Paul A. Weston,Pamela Whittaker,Sara Widaa,Nicholas W. Wood,Gil McVean,John D. Reveille,B P Wordsworth,Matthew A. Brown,Peter Donnelly +92 more
TL;DR: In this paper, the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 x 10(-8) in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all their datasets (p < 5x 10(-6) overall, with support in each of the three datasets studied).
Journal ArticleDOI
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist
Ivona Aksentijevich,Seth L. Masters,Polly J. Ferguson,Paul Dancey,Joost Frenkel,Annet van Royen-Kerkhoff,R. M. Laxer,Ulf Tedgård,Edward W. Cowen,Tuyet-Hang Pham,Matthew G. Booty,Jacob D. Estes,Netanya G. Sandler,Nicole Plass,Deborah L. Stone,Maria L. Turner,Suvimol Hill,John A. Butman,Rayfel Schneider,Paul Babyn,Hatem El-Shanti,Elena Pope,Karyl S. Barron,Xinyu Bing,Arian Laurence,Chyi-Chia Richard Lee,Dawn Chapelle,Gillian I. Clarke,Kamal Ohson,Marc Nicholson,Massimo Gadina,Barbara Yang,Benjamin D. Korman,Peter K. Gregersen,P. Martin van Hagen,A. Elisabeth Hak,Marjan Huizing,Proton Rahman,Daniel C. Douek,Elaine F. Remmers,Daniel L. Kastner,Raphaela Goldbach-Mansky +41 more
TL;DR: The term deficiency of the interleukin-1-receptor antagonist, or DIRA, is proposed to denote this autosomal recessive autoinflammatory disease caused by mutations affecting IL1RN, resulting in life-threatening systemic inflammation with skin and bone involvement.
Journal ArticleDOI
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Lam C. Tsoi,Sarah L. Spain,Sarah L. Spain,Jo Knight,Eva Ellinghaus,Eva Ellinghaus,Philip E. Stuart,Francesca Capon,Jun Ding,Yanming Li,Trilokraj Tejasvi,Johann E. Gudjonsson,Hyun Min Kang,Michael H. Allen,Ross McManus,Giuseppe Novelli,Lena Samuelsson,Joost Schalkwijk,Mona Ståhle,A. David Burden,Catherine H. Smith,Michael J. Cork,Xavier Estivill,Anne M. Bowcock,Gerald G. Krueger,Wolfgang Weger,Jane Worthington,Rachid Tazi-Ahnini,Frank O. Nestle,Adrian Hayday,Per Hoffmann,Juliane Winkelmann,Cisca Wijmenga,Cordelia Langford,Sarah Edkins,Robert Andrews,Hannah Blackburn,Amy Strange,Gavin Band,Richard D. Pearson,Damjan Vukcevic,Chris C. A. Spencer,Panos Deloukas,Ulrich Mrowietz,Stefan Schreiber,Stephan Weidinger,Sulev Kõks,Külli Kingo,Tõnu Esko,Andres Metspalu,Henry W. Lim,John J. Voorhees,Michael Weichenthal,H.-Erich Wichmann,Vinod Chandran,Cheryl F. Rosen,Proton Rahman,Dafna D. Gladman,Christopher E.M. Griffiths,André Reis,Juha Kere,Juha Kere,Rajan P. Nnair,Andre Franke,Jonathan Nn Barker,Ggoncalo R. Abecasis,James Tt Eelder,Richard Ttrembath,Richard Ttrembath,Kristina Callis Duffin,Cindy Helms,David E. Goldgar,Yun Li,Justin Paschall,Justin Paschall,Mary J. Malloy,Mary J. Malloy,Clive R. Pullinger,Clive R. Pullinger,John P. Kane,John P. Kane,Jennifer M. Gardner,Amy Perlmutter,Andrew Miner,Bing Jian Feng,Ravi Hiremagalore,Robert W. Ike,Enno Christophers,Tilo Henseler,Andreas Ruether,Steven J. Schrodi,Sampath Prahalad,Sampath Prahalad,Stephen L. Guthery,Stephen L. Guthery,Judith Fischer,Wilson Liao,Pui Kwok,Alan Menter,G. Mark Lathrop,Carol Wise,Ann B. Begovich,Alexandros Onoufriadis,Michael E. Weale,Angelika Hofer,Wolfgang Salmhofer,Peter Wolf,Kati Kainu,Ulpu Saarialho-Kere,Sari Suomela,Petra Badorf,Ulrike Hüffmeier,Werner Kurrat,Wolfgang Küster,Jesús Lascorz,Rotraut Mössner,Funda Schürmeier-Horst,Markward Ständer,Heiko Traupe,Judith G.M. Bergboer,Martin den Heijer,Martin den Heijer,Peter C.M. van de Kerkhof,Patrick L.J.M. Zeeuwen,L. Barnes,Linda E. Campbell,Caitriona Cusack,Ciara Coleman,Judith Conroy,Sean Ennis,Oliver FitzGerald,Phil Gallagher,Alan D. Irvine,Brian Kirby,Trevor Markham,W.H. Irwin McLean,Joe McPartlin,Sarah Rogers,Anthony W. Ryan,Agnieszka Zawirska,Emiliano Giardina,Tiziana Lepre,Carlo Perricone,Gemma Martin-Ezquerra,Ramon M. Pujol,Eva Riveira-Muñoz,Annica Inerot,Åsa Torinsson Naluai,Lotus Mallbris,Katarina Wolk,Joyce Leman,Anne Barton,Richard B. Warren,Helen S. Young,Isis Ricaño-Ponce,Gosia Trynka,Fawnda Pellett,Andrew Henschel,Marin Aurand,Bruce F. Bebo,Christian Gieger,Thomas Illig,Susanne Moebus,Karl-Heinz Jöckel,Raimund Erbel,Peter Donnelly,Peter Donnelly,Leena Peltonen,Jenefer M. Blackwell,Elvira Bramon,Elvira Bramon,Matthew A. Brown,Juan P. Casas,Aiden Corvin,Nicholas Craddock,Audrey Duncanson,Janusz Jankowski,Hugh S. Markus,Christopher G. Mathew,Mark I. McCarthy,Colin N. A. Palmer,Robert Plomin,Anna Rautanen,Stephen J. Sawcer,Nilesh J. Samani,Ananth C. Viswanathan,Nicholas W. Wood,Céline Bellenguez,Colin Freeman,Garrett Hellenthal,Eleni Giannoulatou,Matti Pirinen,Zhan Su,Sarah E. Hunt,Rhian Gwilliam,Suzannah Bumpstead,Serge Dronov,Matthew W. Gillman,Emma Gray,Naomi Hammond,Alagurevathi Jayakumar,O. T. McCann,Jennifer Liddle,M. Perez,Simon C. Potter,Radhi Ravindrarajah,Michelle Ricketts,Matthew Waller,Paul A. Weston,Sara Widaa,Pamela Whittaker,Rajan P. Neir,Jonathan Barker,Gonçalo R. Abecasis,James T. Elder,Richard C. Trembath +215 more
TL;DR: A meta-analysis of genome-wide association studies and independent data sets genotyped on the Immunochip identified 15 new susceptibility loci, increasing to 36 the number associated with psoriasis in European individuals, and identified five independent signals within previously known loci.
Journal ArticleDOI
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2) : a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes,Philip J. Mease,Bruce Kirkham,Arthur Kavanaugh,Christopher T. Ritchlin,Proton Rahman,Désirée van der Heijde,Robert Landewé,Philip G. Conaghan,Alice B. Gottlieb,Hanno B. Richards,Luminita Pricop,Gregory Ligozio,Manmath Patekar,Shephard Mpofu +14 more
TL;DR: Subcutaneous secukinumab 300 mg and 150 mg improved the signs and symptoms of psoriatic arthritis, suggesting that secuk inumab is a potential future treatment option for patients with this disorder.